The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Global guidelines for breast cancer screening: A systematic review
Open accessAbstract
OBJECTIVES: Breast cancer screening guidelines could provide valuable tools for clinical decision making by reviewing the available evidence and providing recommendations. Little information is known about how many countries have issued breast cancer screening guidelines and the differences among existing guidelines. We systematically reviewed current guidelines and summarized corresponding recommendations, to provide references for good clinical practice in different countries. METHODS: Systematic searches of MEDLINE, EMBASE, Web of Science, and Scopus from inception to March 27th, 2021 were conducted and supplemented by reviewing the guideline development organizations. The quality of screening guidelines was assessed from six domains of the Appraisal of Guidelines for Research and Evaluation Ⅱ (AGREE Ⅱ) instrument by two appraisers. The basic information and recommendations of the issued guidelines were extracted and summarized. RESULTS: A total of 23 guidelines issued between 2010 and 2021 in 11 countries or regions were identified for further review. The content and quality varied across the guidelines. The average AGREE Ⅱ scores of the guidelines ranged from 33.3% to 87.5%. The highest domain score was "clarity of presentation" while the domain with the lowest score was "applicability". For average-risk women, most of the guidelines recommended mammographic screening for those aged 40-74 years, specifically, those aged 50-69 years were regarded as the optimal age group for screening. Nine of 23 guidelines recommended against an upper age limit for breast cancer screening. Mammography (MAM) was recommended as the primary screening modality for average-risk women by all included guidelines. Most guidelines suggested annual or biennial mammographic screening. Risk factors of breast cancer identified in the guidelines mainly fell within five categories which could be broadly summarized as the personal history of pre-cancerous lesions and/or breast cancer; the family history of breast cancer; the known genetic predisposition of breast cancer; the history of mantle or chest radiation therapy; and dense breasts. For women at higher risk, there was a consensus among most guidelines that annual MAM or annual magnetic resonance imaging (MRI) should be given, and the screening should begin earlier than the average-risk group. CONCLUSIONS: The majority of 23 included international guidelines were issued by developed countries which contained roughly the same but not identical recommendations on breast cancer screening age, methods, and intervals. Most guidelines recommended annual or biennial mammographic screening between 40 and 74 years for average-risk populations and annual MAM or annual MRI starting from a younger age for high-risk populations. Current guidelines varied in quality and increased efforts are needed to improve the methodological quality of guidance documents. Due to lacking clinical practice guidelines tailored to different economic levels, low- and middle-income countries (LMICs) should apply and implement the evidence-based guidelines with higher AGREE Ⅱ scores considering local adaption.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
AGREE II: advancing guideline development, reporting and evaluation in health care
Brouwers, M. C., Kho, M. E., Browman, G. P., Burgers, J. S., Cluzeau, F., Feder, G., Fervers, B., Graham, I. D., Grimshaw, J., Hanna, S. E., et al. (2010) · Canadian Medical Association Journal · doi:10.1503/cmaj.090449 · Cited by 3,790
Breast cancer statistics, 2019
DeSantis, C. E., Ma, J., Gaudet, M. M., Newman, L. A., Miller, K. D., Goding Sauer, A., Jemal, A., & Siegel, R. L. (2019) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21583 · Cited by 3,114
Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Aebi, S., Davidson, T., Gruber, G., & Castiglione, M. (2010) · Annals of Oncology · doi:10.1093/annonc/mdq159 · Cited by 2,842
Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Cardoso, F., Kyriakides, S., Ohno, S., Penault-Llorca, F., Poortmans, P., Rubio, I. T., Zackrisson, S., & Senkus, E. (2019) · Annals of Oncology · doi:10.1093/annonc/mdz173 · Cited by 2,214
Screening for breast cancer: U.S. Preventive Services Task Force recommendation statement
Siu, A. L., & on behalf of the U.S. Preventive Services Task Force (2016) · Annals of Internal Medicine · doi:10.7326/m15-2886 · Cited by 2,094
Oeffinger, K. C., Fontham, E. T. H., Etzioni, R., Herzig, A., Michaelson, J. S., Shih, Y.-C. T., Walter, L. C., Church, T. R., Flowers, C. R., LaMonte, S. J., et al. (2015) · JAMA · doi:10.1001/jama.2015.12783 · Cited by 1,653
Breast Cancer, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology
Gradishar, W. J., Anderson, B. O., Abraham, J., Aft, R., Agnese, D., Allison, K. H., Blair, S. L., Burstein, H. J., Dang, C., Elias, A. D., et al. (2020) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2020.0016 · Cited by 1,584
Effect of Three Decades of Screening Mammography on Breast-Cancer Incidence
Bleyer, A., & Welch, H. G. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1206809 · Cited by 1,367
Long-term effects of mammography screening: updated overview of the Swedish randomised trials
Nyström, L., Andersson, I., Bjurstam, N., Frisell, J., Nordenskjöld, B., & Rutqvist, L. E. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08020-0 · Cited by 1,183
Magnetic resonance imaging of the breast: Recommendations from the EUSOMA working group
Sardanelli, F., Boetes, C., Borisch, B., Decker, T., Federico, M., Gilbert, F. J., Helbich, T., Heywang-Köbrunner, S. H., Kaiser, W. A., Kerin, M. J., et al. (2010) · European Journal of Cancer · doi:10.1016/j.ejca.2010.02.015 · Cited by 992
Breast-Cancer Screening — Viewpoint of the IARC Working Group
Lauby-Secretan, B., Scoccianti, C., Loomis, D., Benbrahim-Tallaa, L., Bouvard, V., Bianchini, F., & Straif, K. (2015) · New England Journal of Medicine · doi:10.1056/nejmsr1504363 · Cited by 962
Miller, A. B., Baines, C. J., To, T. M., & Wall, C. (1992) · Europe PMC (PubMed Central) · Cited by 864
Lee, C. H., Dershaw, D. D., Kopans, D., Evans, P., Monsees, B., Monticciolo, D., Brenner, R. J., Bassett, L., Berg, W., Feig, S., et al. (2010) · Journal of the American College of Radiology · doi:10.1016/j.jacr.2009.09.022 · Cited by 809
Breast Cancer Screening in Women at Higher-Than-Average Risk: Recommendations From the ACR
Monticciolo, D. L., Newell, M. S., Moy, L., Niell, B., Monsees, B., & Sickles, E. A. (2018) · Journal of the American College of Radiology · doi:10.1016/j.jacr.2017.11.034 · Cited by 649
Ohuchi, N., Suzuki, A., Sobue, T., Kawai, M., Yamamoto, S., Zheng, Y.-F., Shiono, Y. N., Saito, H., Kuriyama, S., Tohno, E., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(15)00774-6 · Cited by 616
Nelson, H. D., Fu, R., Cantor, A., Pappas, M., Daeges, M., & Humphrey, L. (2016) · Annals of Internal Medicine · doi:10.7326/m15-0969 · Cited by 611
Efficacy of breast cancer screening by age. New results swedish two-county trial
Tabar, L., Fagerberg, G., Chen, H.-H., Duffy, S. W., Smart, C. R., Gad, A., & Smith, R. A. (1995) · Cancer · doi:10.1002/1097-0142(19950515)75:10<2507::aid-cncr2820751017>3.0.co;2-h · Cited by 557
Breast Cancer Screening and Diagnosis, Version 3.2018, NCCN Clinical Practice Guidelines in Oncology
Bevers, T. B., Helvie, M., Bonaccio, E., Calhoun, K. E., Daly, M. B., Farrar, W. B., Garber, J. E., Gray, R., Greenberg, C. C., Greenup, R., et al. (2018) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2018.0083 · Cited by 511
A Systematic Assessment of Benefits and Risks to Guide Breast Cancer Screening Decisions
Pace, L. E., & Keating, N. L. (2014) · JAMA · doi:10.1001/jama.2014.1398 · Cited by 461
Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2017
Hong, S., Won, Y.-J., Park, Y. R., Jung, K.-W., Kong, H.-J., Lee, E. S., & Registries, T. C. O. P.-B. R. C. (2020) · Cancer Research and Treatment · doi:10.4143/crt.2020.206 · Cited by 437
ACR Appropriateness Criteria Breast Cancer Screening
Mainiero, M. B., Lourenco, A., Mahoney, M. C., Newell, M. S., Bailey, L., Barke, L. D., D'Orsi, C., Harvey, J. A., Hayes, M. K., Huynh, P. T., et al. (2013) · Journal of the American College of Radiology · doi:10.1016/j.jacr.2012.09.036 · Cited by 342
Migowski, A., Silva, G. D. A. E., Dias, M. B. K., Estevez-Diz, M. D. P., Sant’Ana, D. R., & Nadanovsky, P. (2018) · Cadernos de Saúde Pública · doi:10.1590/0102-311x00074817 · Cited by 312
Plevritis, S. K., Munoz, D., Kurian, A. W., Stout, N. K., Alagoz, O., Near, A. M., Lee, S. J., van den Broek, J. J., Huang, X., Schechter, C. B., et al. (2018) · JAMA · doi:10.1001/jama.2017.19130 · Cited by 302
Yip, C.-H., Smith, R. A., Anderson, B. O., Miller, A. B., Thomas, D. B., Ang, E.-S., Caffarella, R. S., Corbex, M., Kreps, G. L., McTiernan, A., et al. (2008) · Cancer · doi:10.1002/cncr.23842 · Cited by 301
Breast Cancer Screening and Diagnosis: A Synopsis of the European Breast Guidelines
Schünemann, H. J., Lerda, D., Quinn, C., Follmann, M., Alonso-Coello, P., Rossi, P. G., Lebeau, A., Nyström, L., Broeders, M., Ioannidou-Mouzaka, L., et al. (2020) · Annals of Internal Medicine · doi:10.7326/m19-2125 · Cited by 286
Monticciolo, D. L., Newell, M. S., Hendrick, R. E., Helvie, M. A., Moy, L., Monsees, B., Kopans, D. B., Eby, P. R., & Sickles, E. A. (2017) · Journal of the American College of Radiology · doi:10.1016/j.jacr.2017.06.001 · Cited by 272
Practice Bulletin Number 179: Breast Cancer Risk Assessment and Screening in Average-Risk Women
(2017) · Obstetrics & Gynecology · doi:10.1097/aog.0000000000002158 · Cited by 258
Qaseem, A., Lin, J. S., Mustafa, R. A., Horwitch, C. A., Wilt, T. J., & for the Clinical Guidelines Committee of the American College of Physicians* (2019) · Annals of Internal Medicine · doi:10.7326/m18-2147 · Cited by 229
Klarenbach, S., Sims-Jones, N., Lewin, G., Singh, H., Thériault, G., Tonelli, M., Doull, M., Courage, S., Garcia, A. J., & Thombs, B. D. (2018) · Canadian Medical Association Journal · doi:10.1503/cmaj.180463 · Cited by 205
ACR Appropriateness Criteria ® Breast Cancer Screening
Mainiero, M. B., Moy, L., Baron, P., Didwania, A. D., diFlorio, R. M., Green, E. D., Heller, S. L., Holbrook, A. I., Lee, S.-J., Lewin, A. A., et al. (2017) · Journal of the American College of Radiology · doi:10.1016/j.jacr.2017.08.044 · Cited by 180
Hoffmann-Eßer, W., Siering, U., Neugebauer, E. A. M., Brockhaus, A. C., Lampert, U., & Eikermann, M. (2017) · PLoS ONE · doi:10.1371/journal.pone.0174831 · Cited by 171
Breast Cancer in Sub-Saharan Africa: Challenges and Opportunities to Reduce Mortality
Pace, L. E., & Shulman, L. N. (2016) · The Oncologist · doi:10.1634/theoncologist.2015-0429 · Cited by 159
Impact of Screening on Breast Cancer Mortality: The UK Program 20 Years On
Massat, N. J., Dibden, A., Parmar, D., Cuzick, J. M., Sasieni, P. D., & Duffy, S. W. (2015) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-15-0803 · Cited by 139
Hoffmann-Eßer, W., Siering, U., Neugebauer, E. A. M., Lampert, U., & Eikermann, M. (2017) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2017.12.009 · Cited by 133
Doubeni, C. A., Gabler, N. B., Wheeler, C. M., McCarthy, A. M., Castle, P. E., Halm, E. A., Schnall, M. D., Skinner, C. S., Tosteson, A. N. A., Weaver, D. L., et al. (2018) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.21452 · Cited by 121
Wang, X., Huang, Y., Li, L., Dai, H., Song, F., & Chen, K. (2018) · Breast Cancer Research · doi:10.1186/s13058-018-0947-5 · Cited by 117
Breast Density and Risk of Breast Cancer in Asian Women: A Meta-analysis of Observational Studies
Bae, J., & Kim, E. H. (2016) · Journal of Preventive Medicine and Public Health · doi:10.3961/jpmph.16.054 · Cited by 96
The Japanese Guidelines for Breast Cancer Screening
Hamashima, C., Chisato Hamashima, C., Hattori, M., Honjo, S., Kasahara, Y., Katayama, T., Nakai, M., Nakayama, T., Morita, T., Ohta, K., et al. (2016) · Japanese Journal of Clinical Oncology · doi:10.1093/jjco/hyw008 · Cited by 84
Quality Assessment of Asthma Clinical Practice Guidelines
Acuña, A., Sánchez-Angarita, E., Plaza, V., Rodrigo, G. J., de, M. M., Gich, I. J., Bonfill, X., & Alonso‐Coello, P. (2013) · CHEST Journal · doi:10.1378/chest.12-2005 · Cited by 82
Urban, C. A., Chala, L. F., Bauab, S. D. P., Schaefer, M. B., dos Santos, R. P., Maranhão, N. M. D. A., Kefalas, A. L., Kalaf, J. M., Ferreira, C. A. P., Canella, E. D. O., et al. (2017) · Radiologia Brasileira · doi:10.1590/0100-3984.2017-0069 · Cited by 73
Reece, J. C., Neal, E. F. G., Nguyen, P., McIntosh, J., & Emery, J. D. (2021) · BMC Cancer · doi:10.1186/s12885-021-08100-3 · Cited by 61
Ming, C., Viassolo, V., Probst-Hensch, N. M., Dinov, I. D., Chappuis, P. O., & Katapodi, M. C. (2020) · British Journal of Cancer · doi:10.1038/s41416-020-0937-0 · Cited by 53
Overview of guidelines on breast screening: Why recommendations differ and what to do about it
Jørgensen, K. J., Kalager, M., Barratt, A. L., Baines, C. J., Zahl, P., Brodersen, J., & Harris, R. (2016) · The Breast · doi:10.1016/j.breast.2016.08.002 · Cited by 44
Screening for Breast Cancer in Women Age 75 Years and Older
Lee, C. S., Moy, L. P., Joe, B. N., Sickles, E. A., & Niell, B. L. (2017) · American Journal of Roentgenology · doi:10.2214/ajr.17.18705 · Cited by 42
Updated results of the Gothenburg Trial of Mammographic Screening
Bjurstam, N., Björneld, L., & Duffy, S. W. (2016) · Cancer · doi:10.1002/cncr.29975 · Cited by 39
Wang, Y., Chen, H., Li, N., Ren, J., Zhang, K., Dai, M., & He, J. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00286 · Cited by 38
Methodological quality of guidelines for management of Lyme neuroborreliosis
Dersch, R. S., Toews, I., Sommer, H., Rauer, S., & Meerpohl, J. J. (2015) · BMC Neurology · doi:10.1186/s12883-015-0501-3 · Cited by 21
Establishing an evidence-base for breast cancer control in developing countries
Lodge, M., & Corbex, M. A. (2011) · The Breast · doi:10.1016/j.breast.2011.01.012 · Cited by 19
Cai, Y., Jiang, L., Gao, Y., Yang, K., He, J., Li, N., & Tian, J. (2021) · Cancer Medicine · doi:10.1002/cam4.3898 · Cited by 9
Cited by
Jost, E., Kosian, P., Jimenez Cruz, J., Albarqouni, S., Gembruch, U., Strizek, B., & Recker, F. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12216833 · Cited by 44
“Especially in women with dense breast tissue, e.g., predominantly in young women or in Asian ethnicity, and for underserved areas, US diagnostics and screening are crucial [196].”
BackgroundDelays in breast cancer presentation, diagnosis, and treatment in young women
Zhang, B. X., Sella, T., Zheng, Y., Kirkner, G. J., Ruddy, K. J., Rosenberg, S. M., Borges, V. F., Schapira, L., Come, S. E., Peppercorn, J. M., et al. (2026) · Cancer · doi:10.1002/cncr.70594
Metadata
- Authors
- Ren, W., Chen, M., Qiao, Y., & Zhao, F.
- Venue
- The Breast
- Publisher
- Elsevier BV
- Published
- 2022-08
- Volume
- 64
- Pages
- 85-99
- ISSN
- 0960-9776 (ISSN-L)
- OpenAlex
- W4224218755
- Cited by
- 325
- References
- 49
- FWCI
- 11.20
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.